• A
• A
• A

Genetically Engineered Mouthwash May Delay Oral Cancer (12/29/2003)
According to early release results recently published in the Journal of Clinical Oncology, an oral mouthwash consisting of a genetically engineered virus that causes the common cold may help delay the development of oral cancer in high-risk patients.

Gene Therapy Appears Effective for Recurrent Head and Neck Cancer (04/18/2002)
According to results recently presented at the annual meeting of the American Association for Cancer Research, higher doses of Advexin® gene therapy appears to improve survival in patients with recurrent, inoperable head and neck cancer.

Cancer Treatment Involving Experimental Gene Therapy (02/08/2002)
Gene therapy is defined as the transfer of new genetic material into a cell for therapeutic benefit. This can be accomplished by: 1) replacing or inactivating a dysfunctional gene, 2) replacing or adding a functional gene, or 3) inserting a gene into a cell to make it function normally.

Early Gene Therapy Trial Fails to Improve Outcomes in Non-Small Cell Lung Cancer (02/08/2002)
An early phase clinical trail evaluating gene therapy for treatment in non-small cell lung cancer failed to provide improved outcomes for patients over chemotherapy alone, according to a recent article published in the Journal of Clinical Oncology. However, gene therapy is still in initial phases of development and warrants further investigation involving different strategies of implementation. The novel field of gene therapy encompasses many different methods of therapy, only one of which was evaluated in this particular trial.

Genetically Engineered Mouthwash May Delay Oral Cancer (12/29/2003)
According to early release results recently published in the Journal of Clinical Oncology, an oral mouthwash consisting of a genetically engineered virus that causes the common cold may help delay the development of oral cancer in high-risk patients.

Gene Therapy Appears Effective for Recurrent Head and Neck Cancer (04/18/2002)
According to results recently presented at the annual meeting of the American Association for Cancer Research, higher doses of Advexin® gene therapy appears to improve survival in patients with recurrent, inoperable head and neck cancer.

Early Gene Therapy Trial Fails to Improve Outcomes in Non-Small Cell Lung Cancer (02/08/2002)
An early phase clinical trail evaluating gene therapy for treatment in non-small cell lung cancer failed to provide improved outcomes for patients over chemotherapy alone, according to a recent article published in the Journal of Clinical Oncology. However, gene therapy is still in initial phases of development and warrants further investigation involving different strategies of implementation. The novel field of gene therapy encompasses many different methods of therapy, only one of which was evaluated in this particular trial.

Cancer Treatment Involving Experimental Gene Therapy (02/08/2002)
Gene therapy is defined as the transfer of new genetic material into a cell for therapeutic benefit. This can be accomplished by: 1) replacing or inactivating a dysfunctional gene, 2) replacing or adding a functional gene, or 3) inserting a gene into a cell to make it function normally.